Related references
Note: Only part of the references are listed.A short history of neuroendocrine tumours and their peptide hormones
Wouter W. de Herder et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Measurement of nonsulfated cholecystokinins
Mikkel Agersnap et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2014)
A Neuroendocrine Tumor Syndrome from Cholecystokinin Secretion
Jens F. Rehfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Beginnings: A reflection on the history of gastrointestinal endocrinology
Jens F. Rehfeld
REGULATORY PEPTIDES (2012)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
The Zollinger-Ellison Syndrome and Mismeasurement of Gastrin
Jens F. Rehfeld et al.
GASTROENTEROLOGY (2011)
The Pathologic Classification of Neuroendocrine Tumors A Review of Nomenclature, Grading, and Staging Systems
David S. Klimstra et al.
PANCREAS (2010)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop
Eftychia Oikonomou et al.
NEUROPEPTIDES (2008)
Procholecystokinin as marker of human Ewing sarcomas
JC Reubi et al.
CLINICAL CANCER RESEARCH (2004)
Cholecystokinin
JF Rehfeld
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR
A Moschetta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
